Therapeutic effect of Korean red ginseng on inflammatory cytokines in rats with focal cerebral ischemia/reperfusion injury

American Journal of Chinese Medicine

Volumn 39, Issue 1, 2011, Pages 83-94

  Lee, Jong Seok ^a   Choi, Han Sung ^a   Kang, Sung Wook ^a   Chung, Joo Ho ^a   Park, Hun Kuk ^a   Ban, Ju Yeon ^b   Kwon, Oh Young ^a   Hong, Hoon Pyo ^a   Ko, Young Gwan ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Brain Ischemia; Cytokines; Interleukins; Korean Red Ginseng; Tumor Necrosis Factor

Indexed keywords

GINSENG EXTRACT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CONTROLLED STUDY; CORNER TURN TEST; CYTOKINE PRODUCTION; DISEASE SEVERITY; GINSENG; KOREAN RED GINSENG; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROLOGIC SEVERITY SCORE; NONHUMAN; PLANT ROOT; PROTEIN BLOOD LEVEL; RAT; REPERFUSION INJURY; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CYTOKINES; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 78751498349     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X1100866X     Document Type: Article

References (27)

1. Aronowski, J., R. Strong and J.C. Grotta. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J. Cereb. Blood. Flow Metab. 17: 1048-1056, 1997.
2. Bu, Y., Z.H. Jin, S.Y. Park, S. Baek, S. Rho, N. Ha, S.K. Park, H. Kim and S.Y. Kim. Siberian ginseng reduces infarct volume in transient focal cerebral ischaemia in Sprague-Dawley rats. Phytother. Res. 19: 167-169, 2005.
3. Choi, K., M. Kim, J. Ryu and C. Choi. Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci. Lett. 421: 37-41, 2007.
4. Dijkhuizen, R.M., A.B. Singhal, J.B. Mandeville, O. Wu, E.F. Halpern, S.P. Finklestein, B.R. Rosen and E.H. Lo. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J. Neurosci. 23: 510-517, 2003.
5. Fisher, M. Characterizing the target of acute stroke therapy. Stroke 28: 866-872, 1997.
6. Haelewyn, B., T. Freret, E. Pacary, P. Schumann-Bard, M. Boulouard, M. Bernaudin and V. Bouët. Long-term evaluation of sensorimotor and mnesic behaviour following striatal NMDAinduced unilateral excitotoxic lesion in the mouse. Behav. Brain Res. 178: 235-243, 2007.
7. Jang, H.I. and H.M. Shin. Wild Panax ginseng (Panax ginseng C.A. Meyer) protects against methotrexate-induced cell regression by enhancing the immune response in RAW 264.7 macrophages. Am. J. Chin. Med. 38: 949-960, 2010.
8. Joo, K.R., H.P. Shin, J.M. Cha, S. Nam and Y. Huh. Effect of Korean red ginseng on superoxide dismutase inhibitor-induced pancreatitis in rats: a histopathologic and immunohistochemical study. Pancreas 38: 661-666, 2009.
9. Joo, S.S., T.J. Won and D.I. Lee. Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo. Planta Med. 71: 476-481, 2005.
10. Karikura, M., T. Miyase, H. Tanizawa, Y. Takino, T. Taniyama and T. Hayashi. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats. Chem. Pharm. Bull. 38: 2859-2861, 1990.
11. Kim, K.Y., M.Y. Kim, H.S. Choi, B.K. Jin, S.U. Kim and Y.B. Lee. Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release. Neuroreport 13: 849-852, 2002.
12. Li, Y., J. Chen, X.G. Chen, L. Wang, S.C. Gautam, Y.X. Xu, M. Katakowski, L.J. Zhang, M. Lu, N. Janakiraman and M. Chopp. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514-523, 2002.
13. Linares, G. and S.A. Mayer. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit. Care Med. 37: S243-S249, 2009.
14. Longa, E.Z., P.R. Weinstein, S. Carlson and R. Cummins. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
15. Lourbopoulos, A., D. Karacostas, N. Artemis, I. Milonas and N. Grigoriadis. Effectiveness of a new modified intraluminal suture for temporary middle cerebral artery occlusion in rats of various weight. J. Neurosci. Methods 173: 225-234, 2008.
16. Nudo, R.J. Recovery after damage to motor cortical areas. Curr. Opin. Neurobiol. 9: 740-747, 1999.
17. Oh, G.S., H.O. Pae, B.M. Choi, E.A. Seo, D.H. Kim, M.K. Shin, J.D. Kim, J.B. Kim and H.T. Chung. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysa ccharide. Cancer Lett. 205: 23-29, 2004.
18. Peroulis, N., A.P. Kourounakis, M. Yiangou, D. Paramythiotis, K. Kotzampassi and L. Hadjipetrou. Effects of the novel non-steroidal anti-inflammatory compound [N-(2-thiolethyl)-2-f2-[Ń- (2,6-dichlorophenyl) amino] phenylg acetamide on cytokines and apoptosis in ischaemic rat brain. Arzneimittelforschung 56: 688-694, 2006.
19. Smolinski, A.T. and J.J. Pestka. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents apigenin (chamomile), ginsenoside Rb(1) (ginseng) and parthenolide (feverfew). Food Chem. Toxicol. 41: 1381-1390, 2003.
20. Spera, P.A., J.A. Ellison, G.Z. Feuerstein and F.C. Barone. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251: 189-192, 1998.
21. Sun, H., H. Zhao, G.M. Sharpe, D.M. Arrick and W.G. Mayhan. Effect of chronic alcohol consumption on brain damage following transient focal ischemia. Brain Res. 1194: 73-80, 2008.
22. Wu, C.F., X.L. Bi, J.Y. Yang, J.Y. Zhan, Y.X. Dong, J.H. Wang, J.M. Wang, R. Zhang and X. Li. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int. Immunopharmacol. 7: 313-320, 2007.
23. Xiaoguang, C., L. Hongyan, L. Xiaohong, F. Zhaodi, L. Yan, T. Lihua and H. Rui. Cancer chemopreventive and therapeutic activities of red ginseng. J. Ethnopharmacol. 60: 71-78, 1998.
24. Zaremba, J., P. Skrobanski and J. Losy. Tumour necrosis factor-alpha is increased in the cerebrospinal fluid and serum of ischaemic stroke patients and correlates with the volume of evolving brain infarct. Biomed. Pharmacother. 55: 258-263, 2001.
25. Zhang, B., R. Hata, P. Zhu, K. Sato, T.C. Wen, L. Yang, H. Fujita, N. Mitsuda, J. Tanaka, K. Samukawa, N. Maeda and M. Sakanaka. Prevention of ischemic neuronal death by intravenous infusion of a ginseng saponin, ginsenoside Rb(1), that upregulates Bcl-x(L) expression. J. Cereb. Blood Flow Metab. 26: 708-721, 2006.
26. Zhang, Z., M. Chopp, A. Goussev and C. Powers. Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res. 784: 210-217, 1998.
27. Zhao, Y., W. Li, P.C. Chow, D.T. Lau, N.T. Lee, Y. Pang, X. Zhang, X. Wang and Y. Han. Bis(7)- tacrine, a promising anti-Alzheimer's dimer, affords dose- and time-dependent neuroprotection against transient focal cerebral ischemia. Neurosci. Lett. 439: 160-164, 1999.